Urethane-induced cortical slow wave activity (SWA) spreads into the basal ganglia in dopamine (DA)-depleted rat models of Parkinson's disease (PD). During physiological sleep, SWA is powerfully expressed at the beginning of night and progressively reduced during sleep-time reflecting the sleep need. However, its underlying slow oscillations may contribute directly to modulate cortical plasticity.
Introduction
SWA consists of a slow electroencephalogram (EEG) oscillation ranging between 0.1 and 4 Hz, in which the depolarized up-state is sustained by the activity of cortical neurons, while the hyperpolarized down-state is characterized by widespread cortical neuronal silence (Steriade et al., 2001 ). The number of neurons synchronously engaged in the depolarized and hyperpolarized state determines the amplitude of the SWA (Steriade et al., 2001) . Urethane anesthesia is able to induce cortical SWA which is similar to the physiological SWA of non-rapid eye movement (NREM) (Fox and Armstrong-James, 1986; Steriade et al., 1993) and therefore this anesthetic has been used as a model to investigate central mechanisms underlying sleep (Crook and Lovick, 2016; Pagliardini et al., 2013b Pagliardini et al., , 2013a . Particularly, during SWA, cortical neurons show the same electrophysiological characteristics in both urethane anesthesia and NREM sleep (Clement et al., 2008; Steriade et al., 1993) . Thus, it has been postulated that urethane most likely promotes unconsciousness by activating the brain mechanisms involved in natural sleep (Clement et al., 2008) . In animal models of Parkinson's disease (PD), urethane-induced cortical SWA powerfully spreads within the basal ganglia (Galati et al., 2009; Magill et al., 2001; Tseng et al., 2001 ) and this evidence has been linked to an excessive synchronization between cortex and basal ganglia in the dopamine (DA) depleted state (Hammond et al., 2007) interfering with motor program selection.
Indeed, DA depletion also alters the corticostriatal synaptic plasticity, as has emerged in in vitro studies (Picconi et al., 2003) but also in in vivo experiments (Charpier and Deniau, 1997) . Of note, the corticostriatal-evoked potentials (CS-EPs) change their response in relation to both sleep and DA denervation (Bateman et al., 1999; Galati et al., 2015; Poewe and Hogl, 2000; Rye and Jankovic, 2002; Stefani et al., 2006) .
In physiological conditions, the amplitude of the SWA during NREM not only reflects the sleep needed (Tononi and Cirelli, 2014) but could also contribute to the modulation of synaptic plasticity (Tononi and Cirelli, 2014) . Accordingly, recent evidence has demonstrated that sleep shrinks synapses of sensory-motor cortex in terms of synaptic interface and volume (de Vivo et al., 2017) .
Indeed, the cortical sleep-like oscillations induced through electrical stimulation of the medial lemniscus modulates glutamatergic synaptic plasticity (Chauvette et al., 2012) . Accordingly, the corticocorticalevoked potentials (CC-EPs), representative of the global cortical synaptic strength (Rall, 1967) , increase with time spent awake and decrease with time spent asleep .
Therefore, SWA might play a dual role in a feedback control loop in which synapses with stronger efficiency produce a larger SWA amplitude that subsequently operates an homeostatic (Nelson and Turrigiano, 2008) reduction of synaptic strength (Olcese et al., 2010) . The long-lasting depression of excitatory postsynaptic potentials could be triggered by the oscillatory nature of the SWA (Czarnecki et al., 2007; Nelson and Turrigiano, 2008) .
Given these premises, we investigate the effect and time-course of long-lasting urethane-induced SWA on synaptic transmission measured by an input-output (I-O) curve of the CC-EP and CS-EP. Subsequently, we explore the impact of chronic DA depletion and DAergic treatment on these evoked responses and on SWA changes.
We hypothesize that dopaminergic denervation strongly affects SWA and the related evoked potentials. We used the evoked field potentials because they are a reliable tool for studying synaptic communication and especially excitatory post-synaptic potentials in vivo (Galiñanes et al., 2011) . Moreover, the monosynaptic connection of the CC-EP and CS-EP lead to a straightforward identification of the evoked response (Galiñanes et al., 2011; Prosperetti et al., 2013; Vyazovskiy et al., 2008) that is linked to synaptic strength (Galiñanes et al., 2011; Rall, 1967; Vyazovskiy et al., 2008) . We focused our study on frontal motor cortex evoked responses because the most substantial increase after prolonged wakefulness, as measured by SWA power, has been described within this region (Borbély and Achermann, 1999; de Vivo et al., 2017) .
Methods

Animals
Experimental procedures were carried out on 16 adult male Sprague-Dawley rats (Harlan, Udine, Italy) that weighed between 170 and 200 g, corresponding to six weeks of age. The study was conducted at the Laboratory for Biomedical Neurosciences (LBN) in compliance with Swiss laws on animal experimentation and the National Institute of Health's Guide for the Care and Use of Laboratory Animals. The study was approved by Ticino veterinary authorities. All procedures were performed with the intention of minimizing animal discomfort and stress. The rats were kept on a regular light-dark cycle (lights on at 08:00 am, lights off at 08.00 pm; room temperature 20-22°C) and were given food (Harlan RM Diet, Udine, Italy) and water ad libitum. The study design and the experimental procedures are depicted in Fig. 1A , B.
Unilateral Parkinsonian 6-OHDA-lesioned model
A unilateral (right hemisphere) DA denervation was performed on 10 rats according to a standard protocol (Galati et al., 2008; Prosperetti et al., 2013; Salvadè et al., 2016) . The rats were anesthetized with 1.5-2.5% isoflurane in oxygen and were mounted on a stereotaxic instrument (Stoelting Co., Wheat Lane, Wood Dale, IL, USA). Body temperature was maintained at 37°C-38°C with a heating pad (Stoelting Co., Wheat Lane, Wood Dale, IL, USA) that was placed beneath the animal. After a subcutaneous injection of the local anesthetic lidocaine, a midline scalp incision was made and a hole (Ø~1.0 mm) was drilled in the skull on the right side. The neurotoxin was diluted with 30 mM saline solution of 6-hydroxydopamine (6-OHDA) containing 0.03% of ascorbic acid and was injected into the medial forebrain bundle (MFB; coordinates: 4.0 mm posterior of the bregma, 1.3 mm laterally of the midline and 7.0 mm beneath the cortical surface). Injections of 3 μl of 6-OHDA were administered through a 30-gauge cannula connected to a 10 μl Hamilton syringe over a period of 3 min. The injection of the neurotoxin was preceded by a bolus of desipramine (25 mg/kg, i.p.) in order to minimize the uptake of 6-OHDA by noradrenergic neurons. Electrophysiological recordings were carried out two weeks after 6-OHDA injection.
Tyrosine hydroxylase immunohistochemistry
After completing the recordings, the 10 rats were sacrificed with an i.p. overdose of urethane. The brains were removed immediately, and then frozen at −20°C. We measured the degree of dopaminergic damage within the substantia nigra compacta (SNc), the ventral tegmental area (VTA) and the ipsilateral striatum by tyrosine hydroxylase (TH) immunostaining (Fig. 1C) , as reported elsewhere (Galati et al., 2008 (Galati et al., , 2010 (Galati et al., , 2015 Prosperetti et al., 2013) . Briefly, coronal brain 40-μm-thick sections were cut with an Oxford vibratome across the entire rostrocaudal extent of the striatum and midbrain. Free-floating sections were washed three times with Tris-buffered saline, pH 7.4, and endogenous peroxidase activity was inactivated by Tris-buffered saline containing 2% H 2 O 2 . The sections were rinsed with Tris-buffered saline (0.1% Triton X-100 and 2% normal goat serum) and incubated with 2% normal goat serum followed by overnight incubation at 4°C with mouse anti-TH primary antibodies (1:2000; anti-TH Chemicon, Millipore). Primary antibodies were detected using a secondary antibody (goat anti mouse IR800, Rockland, Gilbertsville). Sections were then rinsed with Tris-buffered saline, mounted on gelatin-coated slides, dehydrated, and cover-slipped with Permount, observed and photographed with a light microscope. All histological samples showed absence of TH reaction with a preserved VTA ipsilateral to 6-OHDA injection.
Electrophysiological recordings
The electrophysiological recordings were performed under urethane anesthesia injected at the same hour of the day (8.00 am, 1.4 mg/kg, i.p.) maintaining the body temperature at 37°C-38°C with a heating pad (Stoelting Co., Wheat Lane, Wood Dale, IL, USA) that was placed beneath the animal. We continuously recorded the ECoG for~8 h (7.77 ± 1.53 h in all animals, n = 16) and performed the I-O curves of the CC-EP and the CS-EP starting at the same hour in the morning (at 10.00 am), and then every 2 h during six consecutive hours in normal (n = 6) and untreated Parkinsonian rats (n = 5; Fig. 1A, B ). An additional group of Parkinsonian animals (n = 5) was injected with the DAagonist apomorphine (APO, 0.05 mg/kg, s.c.) 10 min before each I-O curve. APO is able to produce an improvement of motor function 5 min after s.c. bolus administration lasting from 30 to 90 min (Gancher et al., 1989) . Two 1 mm diameter golden screw electrodes (gold plated screws, conical cross S1, Svenska Dentorama AB) were implanted in the frontal right and left cortices (coordinates: 2 mm anterior of the bregma, 3 mm laterally to the midline) under urethane anesthesia (Salvadè et al., 2016) . Furthermore, a tungsten recording electrode with an impedance of~0.1 MΩ (TM33B01, World Precision Instruments, FL, USA) was implanted into the striatum (coordinates: 0.48 mm anterior of the bregma, 3.5 mm lateral to the midline and 4 mm ventral to the cortical surface) (Galati et al., 2015) . One reference epidural screw electrode was placed over the right cerebellar hemisphere.
Data acquisition and stimulation protocol
The signal was amplified (gain: 1 K, band-pass filter: 1 Hz-3 kHz; Iso-DAM8, World Precision Instruments, FL, USA), digitized (sampling rate: 10 kHz; Cambridge Electronic Devices, Cambridge, UK), and stored in a computer for offline analysis. The stimulation protocol consisted of constant current pulses with the following parameters: 0.3 ms duration at 0.1 Hz, 1-10 mA (AM-systems, Isolated Pulse Stimulator, Model 2100). The I-O characteristics of synaptically evoked intercallosal and cortico-striatal field potential responses were determined by increasing stimulation intensity stepwise from threshold to saturating response (from 1 to 10 mA). For each stimulation intensity, amplitudes of ten evoked responses were averaged. We sampled the CC-EP and the CS-EP every 2 h for a total of 8 h of recordings: 10.00 am, 12.00 pm, 2.00 pm, 4.00 pm (Fig. 1A) .
The response of the CC-and the CS-EP consisted of a complex stereotyped sequence of field potentials, which typically consisted of a positive-negative-positive (P1-N2-P2, Fig. 2D ) waveform. P1 amplitude augmented with increased stimulating current (Galiñanes et al., 2011; Ryan et al., 1986 ). An earlier negative component (N1) as described elsewhere (Ryan et al., 1986) , was likely masked by the stimulation artifact. The amplitude of the evoked local field potentials was determined as the voltage difference between the N2 peak and the subsequent P2 peak.
Changes in the current required for an evoked response, i.e. the excitability, were determined by plotting the amplitude and the slope values of the CC-EP or the CS-EP during each current step vs. the intensity of the current injected.
Data and statistical analysis
In order to demonstrate the long-lasting stability of the urethaneinduced SWA, we measured the content of dominant power in the range of 0-48 Hz during the all ECoG recordings using a fast Fourier transform (FFT) algorithm with length sections of 60 s and an FFT resolution of 4096 (SUDSA22 script, Spike2 software; CED). The same software calculated the total power of delta (0.1-4 Hz), theta (5-7 Hz), beta (8-13 Hz) and gamma (15-35 Hz) for 10 min before each stimulation protocol (10.00 am, 12.00 pm, 02.00 pm, 04.00 pm). To detect changes in the total power at the different hours, we used a non-parametric repeated-measures two-way ANOVA followed by a Dunnett's multiple comparisons test.
Data relating the EP amplitude to different stimulus strengths were first analyzed across all groups with an ANOVA for repeated measures which demonstrated, as expected, an overall highly significant effect of stimulus strength on the amplitude but no significant difference between the three groups in the I-O curves (data not shown, SPSS for Windows v9, SPSS; Chicago, IL). Therefore, we expressed all amplitude and slope values as percentages of the plateau at baseline (set to 100%) and analyzed the time course of the I-O curves by nonlinear least squares curve fitting using the GraphPad Prism, version 6.01 (GraphPad Software, Inc.). The individual curves at different intervals (10.00 am, 12.00 pm, 2.00 pm, and 4.00 pm) describing the relationship between output spike amplitude/slope (y) and stimulus intensity (x) at each stage of the cycle were fitted to a sigmoidal four-parameter Boltzmann function:
A and D are the expected maximum and minimum responses, respectively. B is the Hill slope coefficient, and V50 is the stimulus strength expected to generate a half-maximal amplitude/slope response of the EP. The amplitudes and slope recorded at the highest stimulation intensities were not significantly different across time-points (data not shown) within each group and the maximum A was thus set to 100%. Constrained curve fitting (between 0% and 100%) and extra sum-ofsquares F test were then utilized to test the possible differences between the V50 across all three groups of animals.
Furthermore, the four V50 values were also calculated by nonlinear least squares curve fitting at each hour for each animal using the unconstrained raw amplitude values (10.00 am, 12.00 pm, 02.00 pm, 04.00 pm) and were compared by a repeated-measure one-way ANOVA followed by a Dunnett's multiple comparisons test.
The percentage SWA total power and V50 ratio between end (04.00 pm) and beginning (10.00 am) was used for Pearson's correlation analysis.
Results
Urethane caused a robust cortical slow wave activity
In all animals (n = 16), we recorded the ECoG activity from both hemispheres. As previously described (Galati et al., 2010; Prosperetti et al., 2013; Steriade et al., 1993 Steriade et al., , 2001 ) the urethane anesthesia caused robust and persistent SWA of 0.1-4.0 Hz with large amplitude. Furthermore, the ECoG spectral analysis demonstrated that the dominant frequency remained within the SWA range (< 3 Hz, Fig. 2A ) throughout the time course of the anesthesia in all animal groups, attesting the stability of the anesthesia.
Urethane decreased the total power in slow wave activity range only in normal animals
Although the SWA range (0.1-4 Hz) was the dominant frequency, its total power changed significantly during the 8 h of urethane anesthesia. In fact, the total power of the SWA decreased significantly during the four different hours (10.00 am, 12.00 pm, 02.00 pm, 04.00 pm) and between the three groups of rats (ANOVA, F 3,39 = 5.26; P = 0.0038; F 2,13 = 4.74; P = 0.0283, respectively). However, only normal animals showed a significant decrease of the total power between 10.00 am and the following hours (n = 6; P < 0.05; 10.00 am vs. 12.00 pm: mean difference 0.062; 95% CI of difference 0.027 to 0.097, 10.00 am vs. 02.00 pm: mean difference 0.068, 95% CI of difference 0.033 to 0.103; 10.00 am vs. 04.00 pm: mean difference 0.068, 95% CI of difference 0.033 to 0.103; Fig. 2B ). In Parkinsonian untreated (n = 5) and treated with APO (n = 5) animals, there were no clear changes (P > 0.05) of the SWA total power (Fig. 2B) . Of note, the total delta power at 10.00 am in normal rats (n = 6) was significantly higher than in nontreated (6-OHDA, n = 5) and treated (6-OHDA + APO, n = 5) Parkinsonian animals (P < 0.001, Control vs. 6-OHDA: mean difference 0.079; 95% CI of difference 0.040 to 0.118, Control vs. 6-OH-DA + APO: mean difference 0.053, 95% CI of difference 0.014 to 0.092; Fig. 2C ).
The total power of theta (5-7 Hz), beta (8-13 Hz) and gamma (15-35 Hz) remained unchanged during the time course in all groups (data not shown).
Urethane changed the corticocortical-and corticostriatal-evoked potentials excitability in normal rats
In all animals (n = 16), the CC-EP and CS-EP amplitudes increased as a function of stimulus intensity, best fitted with a sigmoidal relationship. The four I-O curves of both the CC-EP and the CS-EP amplitude performed every 2 h (10.00 am, 12.00 pm, 2.00 pm, and 4.00 pm) progressively shifted with time of recording (Fig. 3A, B upper plots). Non-linear regression analysis of the CC-EP and CS-EP amplitude demonstrated that best fitted curves were significantly different (CC-EP: F 6,32 = 23.10, P < 0.001; CS-EP: F 6,32 = 8.702, P < 0.001; Fig. 3A , B upper plots). The V50, that is the stimulus strength able to give a halfmaximal amplitude response of the EP, was lower for the I-O curves at 10.00 am (Fig. 3A , B lower plots) suggesting a stronger synaptic coupling (i.e. synaptic efficiency) because low current strength is required to drive both the CC-and the CS-EP (Tables 1 and 2 ). The fit of the subsequent I-O curves (12.00 pm, 2.00 pm, and 4.00 pm) showed a V50 increase attesting to a reduction of the excitability of the evoked responses (Tables 1 and 2 ; Fig. 3A , B lower plots). For all the animals (n = 16), we calculated the ECoG dominant frequency expressed during the time course of the urethane anesthesia. The lines represent the mean dominant frequency in the control (turquoise, n = 6) and in Parkinsonian (red, n = 10). As shown both control and Parkinsonian expressed constantly a dominant frequency below 3 Hz within the delta SWA range. B. The total power of the delta frequency range (0.1-4 Hz) was calculated for 10 min before each four I-O curves (10.00 am; 12.00 pm; 02.00 pm; 04.00 pm). We found significant decreases of the delta total power between 10.00 am and the following hours (12.00 pm; 02.00 pm; 04.00 pm) only in the control animals. We did not observed significant changes in both 6-OHDA and 6-OHDA APO treated rats although the latter show a tendency to have higher values at 10.00 am and 12.00 pm. C. The total power of the delta frequency range (0.1-4 Hz) was calculated for 10 min before each four I-O curves (10.00 am; 12.00 pm; 02.00 pm; 04.00 pm). We observed a significant difference only at the end of the awake period (10.00 am) in normal animals. Data are expressed as mean ± SEM; * = P < 0.05; n.s. = not significant; § = P < 0.001 Control vs. 6-OHDA and Control vs. 6-OHDA + APO. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
The four V50 values of the CC-and the CS-EP obtained at 10.00 am, 12.00 pm, 2.00 pm, and 4.00 pm were significantly different (CC-EP: F 1.2,6.2 = 6.058, P < 0.05; CS-EP: F 1.7,8.7 = 4.914, P < 0.05; Fig. 3A,  B) . Multiple comparison analysis showed a statistical difference in both the CC-and the CS-EP at 4.00 pm versus 10.00 am (Fig. 3A , B lower plots).
Effect of urethane on the corticocortical-and corticostriatal-evoked potentials excitability in Parkinsonian rats
In 6-OHDA animals (n = 5), non-linear regression analysis of the CS-EP amplitude demonstrated that best-fitted I-O curves were not significantly different, leading to a shared curve for all 4 h (F 6,192 = 0.410, P > 0.05; Fig. 4 upper plot) . The V50 values were not significantly different from each other (F 1.1,4.4 = 0.793, P = 0.43; Fig. 4 lower plot, Table 3 ).
In the Parkinsonian animals treated with APO (n = 5), non-linear regression analysis of the CS-EP amplitude demonstrated that the bestfitted I-O curves were significantly different (F 6,192 = 2.411, P < 0.05; Fig. 5 upper plot) . In contrast to what was observed in control animals, the I-O curve at 2.00 pm was the most leftward followed by the I-O curves at 12.00 pm, 4.00 pm, and 10.00 am (Fig. 5 upper plot, Table 4 ). The four V50 values of the CS-EP obtained at the 10.00 am, 12.00 pm, 2.00 pm, and 4.00 pm were not significantly different (F 2.2,9.0 = 0.998, P = 0.41; Fig. 5 lower plot) .
In both Parkinsonian treated and non-treated rats the CC-EP were unaffected by the time spent in urethane anesthesia (data not shown).
3.5. Changes of the total power in the slow wave activity range correlate with the changes of corticostriatal-evoked potentials excitability only in naïve animals
If urethane-induced SWA drives changes of corticostriatal excitability, the evoked response would be expected to vary with the magnitude of the cortical SWA. Hence, the relationship between SWA total power and CS-EP V50 was investigated. A significant negative correlation was found between the percentage of variation (4.00 pm vs. 10.00 am) of both SWA total power and the V50 of the CS-EP only in control animals (r = − 0.88, R 2 = 0.790, P < 0.01, n = 6; Pearson's correlation, Fig. 6A ). On the other hand, no correlation was observed in either 6-OHDA or 6-OHDA + APO animals (Fig. 6B, C) .
Discussion
Recent evidence suggests that the dopaminergic system is a strong Fig. 4 . Normalized evoked response in 6-OHDA animals (n = 5). The curve fitting of the I-O curve of the CS-EP amplitude was not significant different between the 4 h. A shared curve fit is showed on the plot. V50 = the stimulus strength necessary to give the 50% response; data are expressed as mean. However, the first I-O curve performed on the morning (10.00 am) showed the highest V50 level, i.e. the least excitability. The lower V50 was observed at 02.00 pm when three APO challenges have been performed. V50 = the stimulus strength necessary to give the 50% response; data are expressed as mean. modulator of cortical activity with regard to sleep-wake states. A recent study in humans with lower activity of DA reuptake transporter shows altered SWA after sleep deprivation (Holst et al., 2014) . Indeed, the SWA is involved in pathophysiological aspects of PD. The present findings are obtained from urethane-induced longlasting cortical SWA (Steriade et al., 1993 (Steriade et al., , 2001 ) that is able to drive a cortical pattern comparable to natural sleep (Clement et al., 2008; Crook and Lovick, 2016; Pagliardini et al., 2013a) .
Herein, the main message is twofold: (i) SWA power changes strongly correlates with synaptic efficiency in both cortex and striatum, exclusively in a DA preserved circuitry; (ii) Parkinsonian animals present lower SWA total power at the beginning of the urethane-induced SWA. Particularly, we observed a progressive decrease of the SWA total power along with the cortico-cortical and cortico-striatal excitability measured trough EP responses.
Similarly, in normal subjects the total power of SWA during NREM sleep is highest at sleep onset and decreases proportionally during time spent asleep (Riedner et al., 2007) . Although we did not examine the underlying mechanisms by which synaptic strength declines, we found that it depended on the time spent in urethane-induced SWA and on the integrity of the DAergic system. Indeed, we cannot exclude that DA denervation operates on synaptic efficiency by other factors, not related with SWA changes.
The evoked local field responses are a reliable readout of synaptic transmission suitable for our in vivo study (Galiñanes et al., 2011) . The SWA as well as the amplitude of the evoked responses, reflecting a subthreshold phenomenon, are both directly related to the number of the neurons firing in unison according to the number, the strength, and the distribution of the synaptic bouton Galiñanes et al., 2011; Olcese et al., 2010) . In humans, the SWA increases in parallel with the cortical synaptic strength promoted by learning (Hanlon et al., 2009; Perfetti et al., 2011) . Similarly, in experimental animals the infusion of brain-derived neurotrophic factor (BDNF) increased the cortical synaptic strength and the SWA amplitude . Furthermore, the CC-EPs in rats are higher after wakefulness and lower after sleep period attesting to synaptic upscaling during awake state and downscaling during sleep. Our experimental data are in agreement with the synaptic homeostasis hypothesis (Tononi and Cirelli, 2014 ) (SHY) postulating that the SWA is an index of cortical synaptic strength as well as a measure of sleep mediated synaptic scaling.
The further role of the SWA as a contributor for synaptic downscaling remains without direct evidence but postulated (Tononi and Cirelli, 2014) by the SHY. The underlying slow oscillations of the SWA would promote changes of synaptic efficiency due to the sustained cortical firing during the depolarized up state (Steriade et al., 2001) able to depress synaptic strength as inferred in a computational model analysis (Czarnecki et al., 2007) . Here we show that SWA changes are directly correlated with changes in corticostriatal synaptic strength in healthy animals.
We observed that the total dominant frequency of the ECoG was constantly below 3 Hz during the 8 h of urethane anesthesia, although the total power of the same SWA showed a significant reduction during the four periods of analysis without changes in other frequency bands. These observations could be explained by a sustained urethane-induced cortical SWA that promotes a reduction of its power over time. The negligible effect on the power of other frequency ranges (theta, beta and gamma) supports the view that this effect is specific to SWA. We observed that only the delta, i.e. the SWA power, selectively reduced during the 8 h of robust SWA. This supports a specific SWA mediated effect instead of an unspecific effect of urethane on cortical function. These data are reinforced by the findings on Parkinsonian rats that do not show a clear decay of the delta total power or changes of synaptic efficiency.
An addition, a major result of our study was the higher SWA total power observed in healthy rats at the end of the wake time in comparison to Parkinsonian rats even after dopaminergic treatment. These findings suggest an impairment of synaptic strength build-up during the awake period in DA depleted animals. Indeed, Parkinsonian animals manifest an impairment of plasticity that is restored after levodopa treatment at least at striatal level (Picconi et al., 2003) . Of note, TMS studies have shown a similar impaired cortical plasticity also in drug naïve PD patients (Morgante et al., 2006) .
The lateralized 6-OHDA model could provide for misleading interpretation of the inter-hemisphere study. However, an increased nigrostriatal inter-hemisphere projection has been described after unilateral DA depletion (Pritzel et al., 1983) . With this limitation in mind, in hemi-parkinsonian animals both the SWA power (recorded in the normal hemisphere) as well as the CC-EP remained unchanged during the time spent in urethane anesthesia. At cortical level, APO treatment did not restore this effect. For CS-EP curves, however, DA depletion removed the reduction of excitability and this was restored by the DA agonist (APO). This is in accordance with the lack of cortico-striatal plasticity in vitro that recovers after DAergic treatment (Bagetta et al., 2010) . However, the four I-O curves were different in comparison to normal animals (i.e. the rightward shifted curve was the 10.00 am curve). We hypothesized that due to the pharmacokinetic short-lasting properties of APO (Hudson et al., 1993) , the recovery of the CS-EP is only incomplete. The post-synaptic action of APO could be another key factor for such a partial response.
Furthermore, the relationship between SWA and CS-EP strength was different across all groups. Indeed, naïve rats showed a strong positive correlation between changes of SWA power and of CS-EP V50 suggesting that urethane-induced SWA contributes to controlling both cortical and striatal excitability. In contrast, this type of correlation was completely lost in DA denervated animals and was not recovered by APO treatment. This suggests that only a physiological tonic DA substitution would completely restore the physiological modulation of CS- EP by SWA. In agreement with our findings, the physiological corticostriatal plasticity strongly depends on DA system integrity and striatal DAergic denervation produces resilient biochemical and morphological changes (Calabresi et al., 2007 Picconi et al., 2003) . The DA dependency of the urethane-induced SWA effect was attested to by the partial reversibility of the progressive reduction of synaptic efficacy obtained by APO treatment. The effect observed by DA-agonist treatment exhibits some parallels with the clinical observation of motor performance amelioration after sleep in PD patients featured by longer duration of disease and motor fluctuations (Bateman et al., 1999) . Notably, PD patients with sleep benefit are more frequently under DA-agonist treatment (Bateman et al., 1999) .
We emphasize that DA plays a crucial role for both physiological SWA activity and the homeostatic plasticity adjustment of the corticostriatal synapsis during sleep. This reinforces the need for an adequate DA replacement therapy during day and nighttime. In PD patients, the discontinuation of DA replacement therapy during the night could be responsible for aberrant synaptic changes that over the course of the disease could lead to pathophysiological changes such as observed in dyskinesia Picconi et al., 2003) .
The clinical message could be relevant on the management of PD therapy, suggesting that DA-ergic treatment could be initiated at PD onset with a preference for long lasting molecules able to act also during nighttime when SWA plays a crucial role in homeostatic processes. Clinical counterparts of the present data arise from the observation that continuous antiparkinsonian treatments, such as deep brain stimulation are able to improve the levodopa-induced dyskinesia that is linked to aberrant plasticity.
We are aware of some limitations of the present study: 1) It lacks a comparable anesthetic not able to induce cortical SWA. However, as above mentioned, the isolated effect on delta power suggests an unrelated effect of the anesthetic but rather a specific SWA mediated effect. 2) We do not compare another dopaminergic drug, such as levodopa, in order to investigate putative pre-synaptic DA-mediated mechanism. 3) We do not assess the effect of dopaminergic treatment during the awake period in order to test a putative DA-mediated recovery of build-up synaptic strength.
Despite the above limitations, we can conclude that our results are in line with the hypothesized role of SWA on shaping synaptic strength over longer time scales. This is physiologically achieved during NREM sleep. Furthermore, our results also bear testimony to a fundamental role for physiological DA tone on homeostatic process, regulating SWA during the day and night which requires an adequate DAergic therapy.
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